Related references
Note: Only part of the references are listed.Two Decades of Experience With the Haemophilus influenzae Serotype b Conjugate Vaccine in the United Kingdom
Shamez N. Ladhani
CLINICAL THERAPEUTICS (2012)
Impact of More Than a Decade of Pneumococcal Conjugate Vaccine Use on Carriage and Invasive Potential in Native American Communities
Jennifer R. Scott et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
The Worldwide Impact of the Seven-valent Pneumococcal Conjugate Vaccine
Sean P. Fitzwater et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2012)
Laboratory quality control in a multicentre meningococcal carriage study in Burkina Faso
Paul A. Kristiansen et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2012)
Effectively introducing a new meningococcal A conjugate vaccine in Africa: The Burkina Faso experience
Mamoudou H. Djingarey et al.
VACCINE (2012)
Baseline Meningococcal Carriage in Burkina Faso before the Introduction of a Meningococcal Serogroup A Conjugate Vaccine
Paul A. Kristiansen et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
Eliminating Epidemic Group A Meningococcal Meningitis In Africa Through A New Vaccine
F. Marc LaForce et al.
HEALTH AFFAIRS (2011)
Immunogenicity and Safety of a Meningococcal A Conjugate Vaccine in Africans
Samba O. Sow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Emergence of Epidemic Neisseria meningitidis Serogroup X Meningitis in Togo and Burkina Faso
Isabelle Delrieu et al.
PLOS ONE (2011)
Impact of a Pneumococcal Conjugate Vaccination Program on Carriage among Children in Norway
Didrik F. Vestrheim et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Global epidemiology of meningococcal disease
Lee H. Harrison et al.
VACCINE (2009)
Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity
Martin C. J. Maiden et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Systematic review: Impact of meningococcal vaccination on pharyngeal carriage of meningococci
Stephanie Dellicour et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2007)
Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the united states during the era of widespread PCV7 vaccination, 1998-2004
Lauri A. Hicks et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
The first large epidemic of meningococcal disease caused by serogroup W135, Burkina Faso, 2002
Behima Koumare et al.
VACCINE (2007)
Clonal waves of Neisseria colonisation and disease in the African meningitis belt:: Eight-year longitudinal study in northern Ghana
Julia Leimkugel et al.
PLOS MEDICINE (2007)
Meningococcal meningitis:: Unprecedented incidence of serogroup X-related cases in 2006 in Niger
Pascal Boisier et al.
CLINICAL INFECTIOUS DISEASES (2007)
Molecular epidemiology of Neisseria meningitidis isolated in the African meningitis belt between 1988 and 2003 shows dominance of sequence type 5 (ST-5) and ST-11 complexes
P Nicolas et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination
CL Trotter et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2005)
Neisseria meningitidis:: an overview of the carriage state
SP Yazdankhah et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2004)
On vaccine efficacy and reproduction numbers
CP Farrington
MATHEMATICAL BIOSCIENCES (2003)
Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis
ME Ramsay et al.
BRITISH MEDICAL JOURNAL (2003)
Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination
MCJ Maiden et al.
LANCET (2002)
Activation of cell-mediated immunity following immunization with pneumococcal conjugate or polysaccharide vaccine
T Wuorimaa et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2001)